18 clinical trials matched your search for Lymphoma. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Lymphoma Study of Tazemetostat in Combination with Belinostat in Patients with Relapsed or Refractory Lymphoma Jennifer Amengual, MD
Lymphoma Study of ONO-4685 in Patients with T-Cell Lymphoma Barbara Pro, MD
Lymphoma Study of Axi-cel vs. Chemotherapy in Patients with High-Risk Large B-Cell Lymphoma Ran Reshef, MD
Lymphoma Study of KITE-363 vs. KITE-753 in Patients with B-cell Lymphoma Ran Reshef, MD
Lymphoma Study of Tazemetostat or Zanubrutinib for Patients with Large B-Cell Lymphoma (LBCL) Jennifer Amengual, MD
Lymphoma Study of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma Barbara Pro, MD
Lymphoma Treatment After CAR T-Cell Therapy for Patients with Diffuse Large B-cell Lymphoma (DLBCL) Hua-Jay Cherng, MD
Lymphoma PhasED-seq in Patients with Diffuse Large B-cell Lymphoma (DLBCL) Hua-Jay Cherng, MD
Lymphoma A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Nobuko Hijiya, MD
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Nobuko Hijiya, MD
Cancer Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia Ran Reshef, MD
Leukemia Study of Polatuzumab Vedotin in Combination with Chemotherapy in Subjectswith Richter's Transformation Andrew Lipsky, MD
Brain Cancer Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Brain Tumors Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of BGB-16673 in Patients with Leukemia or Lymphoma Nicole Lamanna, MD
Lung Cancer Study of Durvalumab in Patients with Non-Small Cell Lung Cancer (NSCLC) Benjamin Herzberg, MD
Brain Tumors CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Patients with Relapsed or Refractory PCNSL Fabio Iwamoto, MD
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE